NCT05563883Active, not recruiting
Atrial Fibrillation and Cancer: a Nationwide French Cohort Study
Source: ClinicalTrials.gov · Last updated 3 Oct 2022
Brief summary (registry, in English)
Atrial fibrillation (AF) is a common complication associated with cancer but the risk of AF according to the cancer localization and status as well as the risk of thromboembolisms, bleedings and mortality are poorly known. The objective of this study is to use a very large French nationwide cohort to adress thèses questions.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 5000000 (estimated)
- First submitted
- 24 Sept 2022
- Start date
- 22 Sept 2022
- Primary completion date
- Jan 2030
- Lead sponsor
- University Hospital, Caen
- Diseases
- Atrial fibrillation
- NCT number
- NCT05563883
What you commit to
- Study type: Observational
- Planned participants: 5000000
- From 22 Sept 2022 to the primary completion date, Jan 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- children
Who the study is looking for
- adult hospitalized patients
- with an ICD-10 code discharge from january 2010 to december 2019 in the French national hospital discharge database (PMSI Programme de Médicalisation des Systèmes d'Information)
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Service de Cardiologie, Centre Hospitalier Universitaire Trousseau Coordinator of this site? Confirm its status | Tours | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.